Trader consensus favors "No" at 77% implied probability, reflecting the complete absence of active CDC Level 4 "Avoid All Travel" Travel Health Notices and no recent escalations to this extreme category for any disease. Official CDC surveillance as of mid-May 2026 confirms zero Level 4 designations, with recent activity limited to Level 2 enhancements, such as new chikungunya alerts in Mauritius and dengue warnings across 16 countries amid rising imported cases. A multi-country hantavirus cluster linked to cruise ship travel prompted a Health Alert Network advisory but fell short of travel notice criteria. Ongoing H5N1 avian influenza monitoring shows no human-to-human transmission, while polio and measles upticks remain at lower precaution levels. Level 4 thresholds demand widespread life-threatening risks to travelers, rare outside major pandemics; weekly FluView and WHO updates through December will gauge any shifts in epidemiological trends.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoCDC issues Level 4 warning by December 31?
CDC issues Level 4 warning by December 31?
$71,397 Wol.
$71,397 Wol.
Dec 31, 2026
$71,397 Wol.
$71,397 Wol.
Dec 31, 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus favors "No" at 77% implied probability, reflecting the complete absence of active CDC Level 4 "Avoid All Travel" Travel Health Notices and no recent escalations to this extreme category for any disease. Official CDC surveillance as of mid-May 2026 confirms zero Level 4 designations, with recent activity limited to Level 2 enhancements, such as new chikungunya alerts in Mauritius and dengue warnings across 16 countries amid rising imported cases. A multi-country hantavirus cluster linked to cruise ship travel prompted a Health Alert Network advisory but fell short of travel notice criteria. Ongoing H5N1 avian influenza monitoring shows no human-to-human transmission, while polio and measles upticks remain at lower precaution levels. Level 4 thresholds demand widespread life-threatening risks to travelers, rare outside major pandemics; weekly FluView and WHO updates through December will gauge any shifts in epidemiological trends.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Rynek otwarty: Jan 19, 2026, 3:15 PM ET
Wolumen
$71,397Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Trader consensus favors "No" at 77% implied probability, reflecting the complete absence of active CDC Level 4 "Avoid All Travel" Travel Health Notices and no recent escalations to this extreme category for any disease. Official CDC surveillance as of mid-May 2026 confirms zero Level 4 designations, with recent activity limited to Level 2 enhancements, such as new chikungunya alerts in Mauritius and dengue warnings across 16 countries amid rising imported cases. A multi-country hantavirus cluster linked to cruise ship travel prompted a Health Alert Network advisory but fell short of travel notice criteria. Ongoing H5N1 avian influenza monitoring shows no human-to-human transmission, while polio and measles upticks remain at lower precaution levels. Level 4 thresholds demand widespread life-threatening risks to travelers, rare outside major pandemics; weekly FluView and WHO updates through December will gauge any shifts in epidemiological trends.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Wolumen
$71,397Data zakończenia
Dec 31, 2026Rynek otwarty
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Trader consensus favors "No" at 77% implied probability, reflecting the complete absence of active CDC Level 4 "Avoid All Travel" Travel Health Notices and no recent escalations to this extreme category for any disease. Official CDC surveillance as of mid-May 2026 confirms zero Level 4 designations, with recent activity limited to Level 2 enhancements, such as new chikungunya alerts in Mauritius and dengue warnings across 16 countries amid rising imported cases. A multi-country hantavirus cluster linked to cruise ship travel prompted a Health Alert Network advisory but fell short of travel notice criteria. Ongoing H5N1 avian influenza monitoring shows no human-to-human transmission, while polio and measles upticks remain at lower precaution levels. Level 4 thresholds demand widespread life-threatening risks to travelers, rare outside major pandemics; weekly FluView and WHO updates through December will gauge any shifts in epidemiological trends.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania